Delivery Order SPE2DR25D1201-SPE2DR26FAKMP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $121,701.21 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 12, 2026, with completion scheduled for January 13, 2026. This firm fixed-price, competitively awarded contract—which includes no set-aside designation—will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order valued at $30,717.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (quantity 90) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $111,070.82 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, non-set-aside contract was executed on January 15, 2026, with an ultimate completion date of January 16, 2026, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Jardiance 25 mg tablets (30-count packages) with a ceiling value of $1,077.32 and an ultimate completion date of January 7, 2026. This is a non-set-aside contract awarded through competitive procurement. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $17,157.28 to AmerisourceBergen Drug Corp for 90-count units of Jardiance 25 mg tablets, with an ultimate completion date of January 7, 2026. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order was executed on January 6, 2026, and represents a specific task order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $16,054.07 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a major...
- The Defense Logistics Agency awarded a delivery order valued at $5,118.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on January 6, 2026, with completion expected by January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $6,274.13 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 8, 2026, with an ultimate completion date of January 9, 2026. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award on a full and open basis. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order valued at $4,743.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 14, 2026, with completion scheduled for January 15, 2026. This firm fixed-price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKMPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $28,256.65 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. This non-set-aside award was issued on January 15, 2026, with an ultimate completion date of January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products, specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide. The contract supports critical federal customers including the Defense Health Agency and the U.S. Coast Guard, with Jardiance (empagliflozin), a diabetes medication, being one of many therapeutic products delivered through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 1/14/26 |